Figure Legends
Table 1: Baseline characteristics of studies included in our meta-analysis
Figure 1: A – The forest plot for pooled weighted mean difference (WMD) for change in QTc interval (maximum QTc – baseline QTc) in COVID-19 patients treated with hydroxychloroquine (HCQ) vs. hydroxychloroquine + Azithromycin (HCQ + AZ); B - The forest plot for risk of QTc prolongation > 500 ms in COVID-19 patients treated with hydroxychloroquine (HCQ) vs. hydroxychloroquine + Azithromycin (HCQ + AZ); C - The forest plot for risk of TdP in COVID-19 patients treated with hydroxychloroquine (HCQ) vs. hydroxychloroquine + Azithromycin (HCQ + AZ).
Table 1 Baseline characteristics of studies included in our pooled analysis.